FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Will Ferrell’s ‘The Hawk’ is unfunny and uninspired

Vincent Pastore, 1946-2026

Mexican national faces federal charges after CBP finds $238K in fentanyl inside electric moped

NYPD cop found guilty of chokehold in first conviction since restraint tactic banned after George Floyd death

Detransitioners reveal how doctors pushed them toward life-altering treatment as teens

White House exposes ‘Transshipment Scam’ costing US up to $26B, points finger at China

Live bullet found aboard United flight forces passengers off plane for security sweep at Denver airport

Woke Colorado School District Teaches 5-Year-Olds Sexual Anatomy Using Images So Bad We Refuse to Post Them – By Age 7, It Gets Far Worse

Marco Rubio gets 68 new jobs in epic White House birthday gift inspired by viral meme

Watch: Bystander Appears to Capture New B-21 Raider Stealth Bomber Flying Low Over Wichita

HHS warns Texas hospitals against denying life-saving care to newborn with disability

Exclusive: Oklahoma Police Chief Cancels City’s Flock Safety Contract After Citizens Raise Privacy Concerns

Gun rights groups capitalize after judge reverses decades-old restrictions: ‘Monumental’

Federal appeals court restores Texas mail ballot ID requirements in major election integrity ruling

Legal Expert: Don Lemon’s Legal Battle Could Have Devastating Unintended Consequences for Abortion Clinics

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”